The Good and the Not-So-Good: Excerpts From an Evaluation of the California Stem Cell Agency
The latest performance audit of California's $3 billion stem cell agency reports both pluses and minuses on the agency's work. Here are some excerpts from the $230,000 study, the third such audit of the California Institute for Regenerative Medicine (CIRM).
"CIRM has a collaborative, engaged, and performance-oriented culture. Managers, Board members, and…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.